Prostate Cancer - Nonhormonal drug reduces hot flashes in men treated for prostate cancer
Transdermal Delivery - BCP Veterinary Pharmacy's Transdermal Gels are Easy Way to Medicate Pets
Type 1 Diabetes - Study Tests Oral Insulin to Prevent Type 1 Diabetes
Weight Loss - Calorie density key to losing weight
AARP New York - Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections
Acute Lymphoblastic Leukemia - Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
Acute Promyelocytic Leukemia - Innovive Pharmaceuticals Receives FDA Fast Track Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia
Adverse Drug Reactions - Cardiome and Astellas Announce Positive Results From ACT 2 Trial
Adverse Drug Reactions - Vical Demonstrates Safety and Tolerability of IL-2 DNA Delivery with Electroporation
Agenix - Delayed Despatch of Rights Issue Holding Statements
Alcoholism - European Patent Office Grants Hythiam Patent for Treatment of Alcohol Dependence
Allergies - Avoiding the Ouch: the AAAAI Offers Advice on Stinging Insect Allergies
Allergies - Verona Pharma Signs Deal to Start Pre-clinical Studies on Ground Breaking Hay Fever Drug
Alzheimer Disease - Off-Label Use of Alzheimer's Disease Drugs Drives the Market for Mild Cognitive Impairment
Amicus Therapeutics - Amicus Therapeutics Announces Pricing of Initial Public Offering of 5,000,000 Shares of Common Stock
Amylin Pharmaceuticals, Inc. - Amylin Pharmaceuticals, Inc. Announces Exercise of Initial Purchasers' Option for Additional $75 Million of Convertible Senior Notes
Amyloidosis - Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid a (AA) Amyloidosis
Amyotrophic Lateral Sclerosis - As the Anniversary of the Birth of the Legendary Lou Gehrig Approaches, Researchers Continue to Look for Effective Treatments for the Disease that Bears His Name
Anadys Pharmaceuticals, Inc. - Anadys Pharmaceuticals Announces Promotion of Carol G. Gallagher, Pharm. D., to Senior Vice President, Corporate Development and Commercial Affairs
Biotechnology - Osprey Pharmaceuticals Limited Appoints Former PDL BioPharma Executive Barbara K. Finck, M.D. as Chief Medial Officer and Senior Vice President
Biotechnology - Osteologix Raises Approximately $5 Million in Private Placement Financing
Biotechnology - Royalty Pharma and InNexus Biotechnology Have Completed the Previously Announced Agreement Regarding the Purchase of Royalty Rights Based on DXL Antibody Products
Biotechnology - Senomyx Announces Appointment of Donald Karanewsky, Ph.D., as Senior Vice President, Discovery
Biotechnology - The Expected Value of the Asia-Pacific Biotechnology Market by 2006 End is More than US$ 39.16 Billion
Bioterrorism - Abiomed Appoints Eric A. Rose, M.D., a Leader in Circulatory Care, to Its Board of Directors
Bioterrorism - Panic Over Infected U.S. Citizen is Just the Tip of the Nightmare: New Strains of Tuberculosis Can Be Used as a Powerful Bioterror Weapon
Biovail Corporation - Biovail Files Amended 2006 Annual Report on Form 20-F with United States Securities and Exchange Commission
Bird Flu - CytoDyn Receives Rapidly Updated DNA Flu Vaccine From the University of Massachusetts Medical School
Bird Flu - Hemispherx Presents Evidence of Ampligen Synergies with Existing Antivirals at International Avian Influenza Conference
Bird Flu - Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
Bird Flu - Two Significant Hires Round-Out VaxInnate's Core Management Team
Blue Cross and Blue Shield Association - BCBSA Federal Employee Program Awards Pharmacy Benefit Management Contracts to Caremark, Inc. and Medco Health Solutions Inc.
Brain Cancer - Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study Presented at ASCO
Breast Cancer - ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
Breast Cancer - Biweekly Xeloda Dosing Regimen is Well Tolerated in Advanced Breast Cancer
Breast Cancer - CAELYX Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
Breast Cancer - Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
Breast Cancer - Elbit Medical Imaging Ltd. Announces - InSightec Receives European CE Mark for ExAblate 2000 Treatment of Pain Caused By Bone Metastases
Breast Cancer - Final Data from a Phase 2 Trial Presented at ASCO Specifies Dose-dependent Activity of Adecatumumab (MT201)
Breast Cancer - Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
Breast Cancer - Genomic Health, Inc. Announces Oncotype DX Recurrence Score Influences Treatment Decisions for Physicians and Patients in Prospective Study
Breast Cancer - Genomic Health, Inc. Announces Positive Results from First Study Using Oncotype DX in Node-Positive Breast Cancer Patients
Breast Cancer - GlaxoSmithKline Honors Cancer Research Pioneer Gianni Bonadonna With New ASCO Award and Fellowship
Breast Cancer - GlaxoSmithKline reports positive new data On Tykerb (lapatinib) at the 2007 American Society of Clinical Oncology (ASCO) annual meeting
Breast Cancer - InSightec Receives European CE Mark for ExAblate 2000 Treatment of Pain Caused by Bone Metastases
Breast Cancer - Investigational cancer drug Pertuzumab shows promising results in advanced breast cancer when combined with Herceptin
Breast Cancer - Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
Breast Cancer - New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel
Breast Cancer - Novelos Therapeutics Announces Enrollment of 1st Patient in Phase 2 Breast Cancer Trial at MUSC / Hollings Cancer Center
Breast Cancer - Phase III Ixabepilone Study Demonstrated Significant Improvement in Progression-Free Survival in Patients With Advanced Metastatic Breast Cancer
Breast Cancer - Statement on Exclusive Distribution Agreement made by Medical Solutions
Breast Cancer - Study Finds Dramatic Difference in Survival Rates Among White and Black Women with Advanced Breast Cancer
Breast Cancer - Study Supports Activity of GEMZAR (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
Breast Cancer - Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Breast Cancer - Wheat Germ Extract Inhibits Breast Cancer in Study Published at ASCO 2007 (American Society of Clinical Oncology)
Breast Cancer - Xeloda Plus Avastin Combination Delays Disease Progression in Women with Advanced Breast Cancer
Breast Pain - Symbollon Pharmaceuticals Receives Regulatory Guidance From the United Kingdom
Cadence Pharmaceuticals, Inc. - Cadence Pharmaceuticals Names Hazel Aker, J.D. Senior Vice President, General Counsel and Catherine Hardalo, M.D. Vice President, Clinical Development
Cancer - Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
Cancer - Advanced Viral Research Corp. Hires Public Relations Firm
Cancer - AEterna Zentaris Presents Detailed Phase 1 Results for Anti-Cancer Compound AEZS-108 at ASCO Meeting
Cancer - Argos Selects MODA-EM for Advanced Manufacturing Processes
Cancer - Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
Cancer - ASCO Awards First 'Team Science' Distinguished Service Award to Cancer Cooperative Groups
Cancer - AUSTRIANOVA Completes First Closing of 35 M EURO Series B Financing
Cancer - Cancer Research Technology and the University of Manchester Announce Biomarker Alliance with AstraZeneca
Cancer - ChemGenex Appoints Dr George Morstyn to Board of Directors
Cancer - Constab Pharmaceutical Develops New Tool to Treat Metastatic Colorectal and Other Cancers
Cancer - CRN Emphasizes Importance of Folic Acid Benefits
Cancer - Diatos Announces Positive Clinical Results for its DTS-201 Doxorubicin Prodrug Program
Cancer - EDAP Looking to Accelerate US Study Enrollment With the Upcoming Addition of McMaster University Hospital
Cancer - Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO
Cancer - Formation of clinical advisory panel to advance CYT997 into Phase II trials
Cancer - GE Healthcare and IntrinsiQ Announce Collaboration to Link Clinical Oncology Information within Patient Electronic Medical Records
Cancer - Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
Cancer - Immunicon Seeks Termination of Exclusive Marketing Agreement and Damages from Veridex
Cancer - Jonathan J. Lewis, MD Joins Delcath's Board of Directors
Cancer - Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
Cancer - Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Telik, Inc.
Cancer - Major Study of BSD Medical's Cancer Therapy in Combination With Chemotherapy Highlighted in ASCO News and in Summary Session
Cancer - Millennium Advances Aurora a Kinase Program
Cancer - New Survey of Oral Mucositis Sufferers Reveals Lack of Public Awareness and Information About the Condition
Cancer - Northwest Cancer Specialists and Cancer Center of the Carolinas Recognized for Highest Commitment to Clinical Research at ASCO
Cancer - Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
Cancer - OXiGENE Abstracts Published in ASCO Program
Cancer - Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
Cancer - PhytoMedical To Develop New Class of Antitumour Agents Designed To Bind To DNA and Kill Cancer Cells
Cancer - Promising Cancer Therapeutics Developed by SRI International
Cancer - Rob Frankenberg, Ph.D. Joins Bionovo as Vice President of Drug Manufacturing
Cancer - Trial Results With Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
Cancer - ZIO-101 (Darinaparsin) Phase I Advanced Solid Tumor Data Presented at ASCO
Cancer - ZIO-301 (Indibulin) Interim Phase I Data Presented at ASCO
Cancer Gene Therapy - Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
Cancer Gene Therapy - Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors
Cancer Gene Therapy - Learn of the Use of Nanotechnology in Virology and its Potential for Antiviral Therapeutics
Cancer Therapy - Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
Cancer Vaccines - Biovest to File for Accelerated Conditional Approval of BiovaxID
Cancer Vaccines - CERVARIX, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
Cancer Vaccines - Coley Pharmaceutical Group's Vaccine Adjuvant, VaxImmune, to Enter Phase III Clinical Testing as Part of GlaxoSmithKline's Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer
Cancer Vaccines - HealthShares Announces Changes to the HealthShares Infectious Disease, Respiratory/Pulmonary, Cancer, and Composite Indexes
Cancer Vaccines - IDM Pharma Presents Interim Phase II Data From EP-2101 Lung Cancer Vaccine Clinical Trial
Cancer Vaccines - IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
Cancer Vaccines - ImmunoVaccine Technologies Inc. Scientific Advisory Board Welcomes New Members
Cancer Vaccines - Introgen Announces Positive Phase 2 Clinical Trial Results with INGN 225 Immunotherapy in Patients with Small Cell Lung Cancer
Cancer Vaccines - Kendle Appoints Board-Certified Medical Oncologist
Cancer Vaccines - Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
Cancer Vaccines - Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedical's Electroporation DNA Delivery Technology
Cardiology - ATS Medical Announces Vice President of Marketing
Cardiology - BioLineRx Submits Application to Begin Pilot (Phase 1/2) Clinical Trials of BL-1040 to Treat Damaged Cardiac Tissue Following Acute MI
CARIE - CARIE at Front of Statewide Effort to Counter Drug Industry Marketing
Cell Therapeutics, Inc. - Cell Therapeutics, Inc. (CTI) Announces Filing of a Universal Shelf Registration
Cement - Philips' Innovative Nuclear Medicine Product Offerings Help Users Focus on the Big Picture of the Patient Care Cycle with Highly Detailed Images of Small Lesions
Chemistry - Intradigm Announces Addition of Samuel Zalipsky To Management Team
Chirality - The Discovery of the Violation of Parity in 1956 was More than a Sensation, for Some it was a Shock
Chronic Lymphocytic Leukemia - ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia - Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
Chronic Myelogenous Leukemia - INNOVIVE Pharmaceuticals Presents Additional Phase I Data on INNO-406 for Treatment of Gleevec-Resistant or Intolerant Chronic Myelogenous Leukemia at the American Society of Clinical Oncology Annual Meeting
Clinical Trial Research - Tercica Completes Enrollment of Clinical Trial MS308 Evaluating Once-Daily Treatment with Increlex in Children with Primary IGFD
Clinical Trial Research - Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo
Clinical Trial Research - WorldHeart Announces Levacor VAD Clinical Results and Related Technical Developments
Coatings - MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of a Hydroxyapatite Coated Stent
Colon Cancer - Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New Treatment Benchmark in Patients With Metastatic Colorectal Cancer
Colon Cancer - Emerging Trends in Radioembolization Using Microspheres: a Clinical Workshop Highlights Latest Research and Data Regarding Treatments for Advanced Liver Tumors
Colon Cancer - FOLFOX4 (Eloxatin-based Chemotherapy) After Surgery Improves Overall Survival in Patients With Early (Stage III) Colon Cancer
Colon Cancer - Immunicon Releases ASCO 2007 Podium Presentations
Colon Cancer - Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
Colon Cancer - Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
Colon Cancer - The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
Colon Cancer - YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in colorectal Cancer
Combination Therapy - Adherex To Present ADH-1 and Eniluracil Data At 2007 ASCO Meeting
CombinatoRx - CombinatoRx Adds Sally W. Crawford and W. James O'Shea to Its Board
Connective Tissue Disease - Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension
Contact Lens - VISTAKON Launches Electronic Contact Lens Reminder Service to Help Improve Contact Lens Compliance
Coronary Stents - Abbott Submits XIENCE V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
Coronary Stents - New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
Cramer - Cramer Healthcare Expands with Management and Account Additions
Crucell - Crucell announces resignations of Supervisory Board members, Dr. J?rg Witmer and Dr. Claude Thomann
Cutaneous T-Cell Lymphoma - ONTAK (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
CVS Caremark Corporation - CVS Caremark Wins 3-Year Blue Cross and Blue Shield Federal Employee Program (FEP) Contract Renewal for Retail Pharmacy and Clinical Services
Cyanotech - Cyanotech Issues Statement on Product Integrity
Cytori Therapeutics - Cytori Divests HYDROSORB Surgical Implant Product Line to Kensey Nash for $3.2 Million
Dendrimers - CCM Research Issues Update Report on Starpharma Holdings
Dermatology - Research and Markets: Smith & Nephew Medical Device Company Intelligence Report Available Now
DHC USA Inc. - Nutrition and Beauty Delivered Directly to Your Door
Diabetes - American Diabetes Association Strongly Advises Patients Using Rosiglitazone to See Their Doctor
Diabetes - Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Diabetes - DexCom Receives FDA Approval for Its 7-Day STS Continuous Glucose Monitoring System
Diabetes - Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
Diabetes - Internationally Recognized Physician from India Joins Herbalife's Nutrition Advisory Board
Diabetes - Liberty Signs Multi-Year National Strategic Partnership Agreement with the American Diabetes Association
Diabetes - Termination of Development of Fixed Dose Combination Product of Actos + TAK-536
Diagnostic Assays - SuperArray Bioscience Corporation Licenses PCR and Real-Time PCR Patents from Applied Biosystems
Diagnostic Test - Corgenix AspirinWorks Test Kit Cleared by FDA
Diagnostics - Almac Diagnostics Attends Pre-IDE Meeting with FDA for Colorectal Cancer Diagnostic Derived from FFPE Tissue
Diagnostics - QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
DNA Research - Applied Biosystems Announces Early-Access Program for Its Next-Generation Sequencing Platform
DNA Research - Epidauros expands service with cost-effective solution for blood sampling and shipment
Drug Development - Acorda Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Drug Development - Agilent Technologies Introduces Improvements to Single Quadrupole Mass Spectrometers for Increased Precision, Speed
Drug Development - APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
Drug Development - AstraZeneca Acquires Biologics Manufacturing Facility in Canada
Drug Development - AstraZeneca acquires DSM Biologics manufacturing facility in Canada
Drug Development - Barr Announces Tentative Approval for a Generic Version of Risperdal Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
Drug Development - BioLineRx Introduces Early Development Program
Drug Development - Bioxel Pharma reports First Quarter 2007 Results
Drug Development - Cardiome Announces Filing of New Drug Submission in Canada
Drug Development - Cognos Recognizes Phase Forward for Excellence in Life Sciences Innovation
Drug Development - Commonwealth Biotechnologies, Inc. Completes Acquisition of Tripos Discovery Research Ltd
Drug Development - Cortex and the University of California, Irvine Extend Exclusive Licensing Agreement
Drug Development - Danube Pharmaceuticals Taps Aptuit for Integrated Phase II Drug Development Project
Drug Development - Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
Drug Development - FierceBiotech Names Archemix Corp. as One of the ''Fierce 15'' Biotech Companies of 2007
Drug Development - GenomeQuest, Inc. Signs ARYx Therapeutics As GenomeQuest Customer
Drug Development - Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes
Drug Development - IBC Life Sciences Develops an Antibody Therapeutics Summit Based on New Industry Survey Results
Drug Development - InforSense Expands to Meet Customer Demand for Embedded Enterprise Analytics
Drug Development - Innate Pharma Updates On Its Next Meetings With Analysts and Investors
Drug Development - Innovations in Proteomic Sample Prep: Partnership Between Digilab BioVisioN GmbH and GenWay Biotech, Inc.
Drug Development - Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
Drug Development - Neurogen Announces Continuing Preclinical and Clinical Development Work and Conclusion of Research Component of Collaboration for Investigational Pain Drug
Drug Development - NovaDel Announces Positive Data from Two Studies Comparing Zolpidem Oral Spray to Ambien Tablets
Drug Safety - Cross Country Healthcare Announces Acquisition of AKOS Limited
Drug Safety - Pharmacovigilance Specialist for Drug Safety
Dry Eye Syndrome - ISTA Pharmaceuticals Announces Positive Preliminary Results from Ecabet Sodium Phase IIb Study
Edge Dynamics - Survey Shows Leading Pharmaceutical Manufacturers are Improving Product Launches and Forecast Accuracy by Using Untapped Sources of Daily Sales Data
EKR Therapeutics, Inc. - EKR Therapeutics Expands Its Management Team in Support of Growth Momentum
Emphysema - PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin
Endocrine - GTx Announces Podium Presentation of SARM Preclinical and Clinical Trial Data at Endocrine Society's 2007 Annual Meeting
Endometrial Cancer - ARIAD Presents Positive Efficacy Data On AP23573, Novel mTOR Inhibitor, in Phase 2 Metastatic Endometrial Cancer Trial
Environmental Health - CDC Foundation Announces $1.7 Million Grant to Improve and Standardize Testosterone Measurements in Laboratories Nationwide
Enzo Biochem Inc. - Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
Epidemic - GlaxoSmithKline Launches Educational Campaign in Detroit to Address 'Silent Epidemic' of Genital Herpes Among African American Adults
Epidemiology - Applied Biosystems/ U.S. Department of Defense Contract for Prototype Instrument System to Identify Infectious Diseases Terminated
European Approval - ADVENTRX Pharmaceuticals Receives Designation as a Small/Medium Enterprise by the European Medicines Agency
Experimental Medicine - Protalix Bio Therapeutics Appoint Dr. Ernest Beutler to its Scientific Advisory Board
Experimental Medicine - Protalix BioTherapeutics Appoints Dr. Ernest Beutler to its Scientific Advisory Board
Ferro Pfanstiehl - Ferro Appoints Amy McGann Assistant General Counsel and Assistant Secretary
Financials - Alert B&c Issues Financial Results for Its Second Quarter Ended March 31, 2007
Financials - Angelica Announces First Quarter Fiscal Year 2007 Results
Financing - Boston Millennia Partners Invests in Histogenics Corporation
Financing - Community Catalysts Housing Alliance Announces Partnership with the Tom Hom Group
Financing - Dreamerz Foods Closes on Series B Funding
Financing - Elron Announces New Investment In Radlive
Financing - Emageon and Dell Team to Bring Affordable High-end PACS with Advanced Visualization and 3D Capabilities to Small to Mid-sized Hospitals and Clinics
Financing - Global Med Technologies, Inc. Files Post Effective Amendment Related to Previously Registered Shares
Financing - Halozyme Therapeutics Announces Closing of $32.1 Million Private Financing
Financing - Increased Turnover and EBITDA for Lavipharm Group in Q1 2007
Financing - New Sun Nutrition, Inc. Announces $25 Million Series a Preferred Investment Round Led by Oak Investment Partners
Financing - Tepha, Inc. Announces $10.7 Million Venture Capital Financing
Financing - Viamet Pharmaceuticals Raises $4 Million Round of Financing
Financing - WaferGen Completes Merger and Private Placement of $10.7 Million
flexSCAN, Inc. - CVS Caremark Corporation Signs Advertising Agreement with flexSCAN to Reach 500,000 wellness360 Enrollees
Flu Vaccines - Canadian company Microbix' discovery could save many lives in flu pandemic; its technology to be granted U.S. patent
Flu Vaccines - Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Adjuvant Patch for Influenza at WHO Conference
Flu Vaccines - Medicago Announces First Quarter Results
Follicular Lymphoma - Data Show Improved Response Rate When Zevalin Plus Rituximab Follows Short Course First-Line Treatment in Patients with Follicular Lymphoma
Follicular Lymphoma - Immunomedics Reports New and Updated Clinical Results from Dose De-Escalation Study with hA20 in Lymphoma Patients
Food Poisoning - Governor Rendell Says New Online Restaurant Inspection Reports to Improve Consumer Safety
Food Poisoning - New Contaminant Testing Method from Applied Biosystems/MDS SCIEX Developed To Help Improve Food Safety
Gastric Cancer - S-1, a Novel Oral Fluoropyrimidine, When Combined With Cisplatin, Demonstrates Significant Improvement in Overall Survival of Advanced Gastric Cancer Patients Over S-1 Alone
Gene Therapy - AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy
Gene Therapy - AMT Receives Orphan Drug Designation from FDA for AMT 011 for the Treatment of Lipoprotein Lipase Deficiency
Gene Therapy - Bristol-Myers Squibb Awards Immunicon New Research Services Agreement for Oncology Biomarker Development
Gene Therapy - Cambria Biosciences Announces Collaboration with Pfizer Animal Health in Antiparasitic Drug Discovery
Gene Therapy - Copernicus' Nanoparticle Technology Applied to siRNA
Gene Therapy - Dow AgroSciences Highlights Partnership With Sangamo in Wall Street Presentation
Gene Therapy - PNP Therapeutics Raises $925,000 in Series B Financing Through Birmingham Technology Fund and Phase 1 Holdings
Gene Therapy - VGX Pharmaceuticals to Present at American Society of Gene Therapy Meeting
Gene Therapy - Vical Introduces RapidResponse DNA Vaccine Cell-Free Platform Designed to Accelerate Vaccine Production During Infectious Disease Outbreaks
Genetics & Genomics - Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
Genetics & Genomics - Dr. Patrice Milos Joins Helicos BioSciences as Chief Scientific Officer
Genetics & Genomics - Get the Latest Analysis on the Current Products in the Pharmacogenetics Market
Genetics & Genomics - Kimball Genetics, Inc. Launches the Warfarin DoseAdvise Genetic Test, Ideally Suited for Clinicians to Improve Warfarin Therapy
Genetics & Genomics - VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
GlaxoSmithKline - GlaxoSmithKline Response to New England Journal of Medicine Editorials
Glioblastoma - Celldex Therapeutics Announces Updated EGFRvIII Vaccine Data in Glioblastoma Multiforme Presented at ASCO Annual Meeting
Glioblastoma - Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
Glioblastoma - Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
H. Lundbeck - Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
Hair Loss - Auriga Laboratories Acquires Exclusive U.S. Rights to New Hair Loss Product
Head and Neck Cancer - Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Heart Disease - NASA Technology Helps Detect and Treat Heart Disease and Strokes
Heart Failure - Advanced Cell Technology Enters Into Letter of Intent to Acquire Mytogen, Inc. and Proceed with the Human Clinical Trials Utilizing Myoblasts for the Treatment of Heart Failure
Heart Failure - Patient Enrollment Completed in FIX-HF-5 Clinical Trial
Hematologic Disease - Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Hematology - Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
Hemophilia - Bayer HealthCare Announces Recipients of Prestigious International Hemophilia Nursing Fellowship
Hepatitis B Virus - AcroMetrix Receives 510(k) Clearance for VeriSure Pro HBV Blood Screening Controls
Hepatitis B Virus - Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
Hepatitis C Virus - Amarillo CytoPharm to Conduct Hepatitis C Trial and Seek Regulatory Approval for Amarillo Biosciences' Low Dose Oral Interferon
Hepatitis C Virus - FierceBiotech Names Intarcia Therapeutics as One of the 'Fierce 15' Biotech Companies of 2007
Hepatitis C Virus - Launch of Several Novel Therapies Will Drive Dramatic Near-Term Growth in the Hepatitis C Virus Drug Market
Hepatocellular Cancer - Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Hepatocellular Cancer - Phase 3 Study: Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Highmark Foundation - The Highmark Foundation Announces 2007 Highmark Healthy High 5 School Challenge Grant Winners
HIV/AIDS - AIDS Healthcare Foundation and the Royal Government of Cambodia to Partner in New Free AIDS Treatment Clinic in Koh Thum
HIV/AIDS - AIDS Healthcare Foundation Commends Boehringer's 80% Nevirapine Price Cut in Mexico
HIV/AIDS - Avalere Health Compares FDA Review of Several Categories of Drugs Including Alzheimer's Disease
HIV/AIDS - Beckman Coulter Awarded Second Grant by Imperial College London to Help Fight HIV/AIDS in Resource-Poor Countries
HIV/AIDS - Bio-rad and Beckman Coulter Extend Partnership Agreement
HIV/AIDS - Clinical Care Options Launches Online HIV Drug-Drug Interaction Tool and Downloadable Application for Mobile Devices
HIV/AIDS - Merck's Thai Price Cut Must Come Without Strings on Generics, Says AHF
HIV/AIDS - Mymetics' HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
HIV/AIDS - Royal Government of Cambodia and AIDS Healthcare Foundation to Dedicate Newest AIDS Treatment Center in Partnership in Romeas Haek
HIV/AIDS - Sangamo BioSciences Presents First ZFP Therapeutic Data Demonstrating in Vivo Protection Against HIV
Hodgkin Disease - Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
Hormones - VGX Pharmaceuticals Announces Formation of Animal Health Company
Hyperlipidemia - Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Society's Annual Meeting
IAG Research - Lunesta Continues To Top the Charts As the Most Recalled Prescription Drug Advertising, but Watch Out -- Here Comes the Competition
Immunoassay - Singulex Raises $19.1 Million to Advance Clinical Immunoassays for Drug Development and Health Care
Immunotherapy - Celldex Therapeutics Presents Data from Phase 1 Study of CDX-1307 Immunotherapy at ASCO Annual Meeting
Immunotherapy - Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
Immunotherapy - Fornix starts independent allergy activities in Germany
Inflammation - Neptune Technologies & Bioressources Inc. Business and Market Update
Inspire Pharmaceuticals, Inc. - Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Internal Medicine - Spectral's EAA Proven Effective in Veterinary Applications
Kensey Nash Corporation - Kensey Nash Announces Acquisition of Assets of MacroPore Biosurgery Business Unit from Cytori Therapeutics
Keratosis - Bradley Pharmaceuticals Solaraze and TX Systems B-Lift Featured at European Dermatology Conference
Kidney Cancer - Avastin significantly prolongs progression free survival in advanced kidney cancer
Kidney Cancer - Data Presented at ASCO Showed TORISEL Significantly Increased Quality-Adjusted Survival for Patients With Advanced Renal Cell Carcinoma
Kidney Cancer - FDA Approves Torisel, a New Drug for the Treatment of Advanced Kidney Cancer
Kidney Cancer - Karmanos Phase I Team Presents Posters, Oral Presentations at American Society of Clinical Oncology Annual Meeting
Kidney Cancer - Oxford Biomedica and Sanofi-Aventis Report new TroVax Phase II Trial Results in Renal Cancer
Kidney Cancer - Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show
Kidney Disease - Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
Leukemia - MGI PHARMA Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
Leukemia - Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
Life Sciences - 3M Acquires Rights to PERIDEX Oral Rinse from Zila Inc.
Lung Cancer - Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Lung Cancer - Clinical Data Suggest Potential Versatility of ALIMTA (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Lung Cancer - Encouraging Clinical Activity of GSK's Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
Lung Cancer - Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
Lung Cancer - Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
Lung Cancer - Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
Lupus - Human Genome Sciences and Glaxosmithkline Initiate Second Phase 3 Clinical Trial of Lymphostat-b In Systemic Lupus Erythematosus
Lupus Nephritis - Aspreva announces Fast-Track designation granted by the FDA for CellCept in lupus nephritis
Lymphoma - 8-year Long-term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission With Bexxar
Lymphoma - MabThera Significantly Extends Survival and Cures More Patients With Aggressive Lymphoma than chemotherapy alone
Lymphoma - Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting
Lymphoma - Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
Marketing and Licensing Agreements - Elbit Medical Imaging Ltd. Announces Joint Venture for a Large Scale Luxury Residential Project In Bangalore, India
Marketing and Licensing Agreements - Health Net Completes Joint Venture Transaction to Transition Healthcare Solutions Membership in New York Tri-State Area
Marketing and Licensing Agreements - Solazyme, Inc., and Imperium Renewables, Inc. Enter Into a Biodiesel Feedstock Development Agreement
Mass Spectrometry - BioTrove Launches Enabling Drug-Drug Interaction Applications for RapdiFire Drug Discovery Platform
Mass Spectrometry - Waters Redefines Molecular Characterization Science at ASMS 2007
Medco Health Solutions, Inc. - Medco Awarded BCBSA Federal Employees Program Mail-Service Pharmacy Benefit Management Contract
Mergers & Acquisitions - Enzo Biochem Unit To Acquire Axxora Life Sciences, Inc. Global Reagent Manufacturer and Marketing Company
Mergers & Acquisitions - Fitch: Wellmont Health System (Tennessee) to Acquire 2 Hospitals from HMA
Mergers & Acquisitions - Health Care Property Investors, Inc. to Acquire Slough Estates USA Inc.
Mergers & Acquisitions - Health Care Property Investors, Inc. to Present at NAREIT's Investor Forum
Mergers & Acquisitions - NxStage Medical Announces Agreement to Acquire Medisystems Corporation and Certain Affiliated Entities
Mergers & Acquisitions - Paramount Acquisition Corp. Announces Signing of Definitive Agreement to Acquire Chem Rx, an Institutional Pharmacy Leader
Metagenics, Inc. - Metagenics' Medical Food with Select Kinase Response Modulators (SKRMs) Has Powerful Effect on Metabolic Syndrome, Study Says
Molecular Imaging - MDS Nordion and University of Ottawa Heart Institute Launch Molecular Imaging Centre of Excellence to Advance Innovative Cardiology Research
Molecular Imaging - MDS Nordion partnering with U of O to open $2.2M R&D centre
Monoclonal Antibodies - Abbott's HUMIRA (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
Monoclonal Antibodies - Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
Monoclonal Antibodies - DSM Biologics and Crucell Announce PER.C6 Licensing Deal With Sartorius Biotech GmbH
Monoclonal Antibodies - Extensive Clinical Data on ERBITUX Presented at the 2007 ASCO Annual Meeting
Monoclonal Antibodies - Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
Monoclonal Antibodies - Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
Monoclonal Antibodies - Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
Multiple Sclerosis - Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
Multiple Sclerosis - Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
Multiple Sclerosis - BioMS Medical initiates enrollment in pivotal U.S. phase III multiple sclerosis trial
Multiple Sclerosis - Teva and Active Biotech to Initiate Pivotal Phase III Trial Program of Oral Laquinimod for Relapsing Multiple Sclerosis
Myelodysplastic Syndrome - Cyclacel Reports Phase I Sapacitabine Data in Patients with Advanced Leukemias and Myelodysplastic Syndromes at 2007 ASCO Annual Meeting
Myeloma - EntreMed Presents Phase 2 Results for Panzem Capsules in Multiple Myeloma
Myeloma - Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
Myeloma - Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Announce Strategic New Hires
Myeloma - New Data on Market-Leading VELCADE (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
Myeloma - Pharmion Announces French ATU Granted for Use of Thalidomide for Elderly Patients With Untreated Multiple Myeloma
Myeloma - Revlimid Data Presented at ASCO Demonstrates Impressive Survival Benefit and Stands to Change the Way Physicians Treat Multiple Myeloma
Myeloma - Study Shows VELCADE Plus DOXIL Improves Survival in Previously Treated Patients With Multiple Myeloma
Myeloma - ZIO-101 (Darinaparsin) Early Interim Multiple Myeloma Phase I/II Data Presented at ASCO
Nanomedicine - CytImmune Presents Positive CYT-6091 Data During the American Society of Clinical Oncology Annual Meeting in Chicago
Nanomedicine - NUCRYST Pharmaceuticals appoints Edward Gaj Jr. Vice President, Corporate Development
Nanoparticles - Study Evaluating Novel Combination of nab-paclitaxel and capecitabine for 1st Line Treatment of Metastatic Breast Cancer Presented at the American Society of Clinical Oncology Annual Meeting
Nanotechnology - Affymetrix Arrays Used to Identify Gene Amplification Associated with Breast Cancer
Nanotechnology - Correlogic Systems and JEOL Sign Research and Development Agreement
Nanotechnology - Cyberkinetics Announces United States Patent and Trademark Office Issuance of Patent for Brain Implant System
Nanotechnology - Eksigent Extends Worldwide NanoLC Sales & Service with Southeast Asia Distribution Agreement
Nanotechnology - Epeius Biotechnologies Reaches Out to American Cancer Patients, Gains FDA Approval for Two New Clinical Trials Using Rexin-G for Breast Cancer and Sarcoma
Neuralgia - Valeant Pharmaceuticals to Initiate Study of Retigabine for Pain Associated with Post-Herpetic Neuralgia
Neuropathic Pain - NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
Neutropenia - Cytokinetics Announces the Presentation of Clinical Trials Data at the 2007 Annual Meeting of the American Society of Clinical Oncology
Non-Hodgkin Lymphoma - Favrille Reports Status of Phase 2 Clinical Trial of FavId With Maintenance Rituxan for Indolent B-Cell Non-Hodgkin's Lymphoma
Non-Hodgkin Lymphoma - Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
Non-Small Cell Lung Cancer - New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer - New Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE) in Combination and as a Single Agent for the Treatment of Lung and Ovarian Cancers
Non-Small Cell Lung Cancer - Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer - Pre-menopausal Estrogen Levels Linked to Higher Death Rate Among Women Receiving Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer - Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in First-Line Non-Squamous, Non-Small Cell Lung Cancer
